Upgrade to SI Premium - Free Trial

Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)

September 23, 2026 5:24 AM
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $450.00 price target on Amgen (NASDAQ: AMGN).The analyst comments "AMGN shares ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments